Report Overview
The US AI in Healthcare market size was valued at USD 2.40 billion in 2020 and is forecasted to reach the market size of USD 43.40 billion by 2028, expanding at a compound annual growth rate (CAGR) of 43.6% from 2020 to 2028.
Artificial Intelligence can bring about substantial improvements to any process within the healthcare functions of operation and delivery. In January 2018, the University of Massachusetts Amherst Centre for Data Science partnered with Chan Zuckerberg Initiative (CZI) to fast-track healthcare research and development using artificial intelligence. AI is forecasted to cut down US healthcare costs by USD 150 billion in 2026. In the US, the White House partnered with AI research institutions to mine scientific literature to better understand COVID-19.
AI tools are expected to facilitate and enhance human work and not replace the work of human physicians and other healthcare staff. AI can foster preventative medicine and new drug discovery which significantly improves the quality of healthcare. IBM Watsons ability to pinpoint treatments for cancer patients and Googles healthcare app that organizes and stores healthcare data enabling easy access are some of the developments.
Even amid economic uncertainties due to COVID-19, Healthcare AI companies have gained numerous opportunities to thrive upon owing to the reason that they minimize human interaction, thus minimising the risk of transmission and shielding the frontline workers.
Market Drivers
The US AI in Healthcare market is driven by the influx of large and complex healthcare datasets. The increased demand for minimising healthcare expenditure further drivers the market. The need to cut down hardware costs by maximising computing efficiency fuels the market growth.
In addition to this, the market is driven by growing government initiatives and their collaboration with leading AI companies to promote implementation of AI in Healthcare.
There is an imbalance between the healthcare workforce and the patients. Artificial Intelligence restores this balance, further fuelling the market growth. Increase in use of precision medicines and clinical trial processes demands the deployment of Artificial Intelligence which further propels the market. Increased funding for Research and Development in the field contributes to the growth of the market. It is also driven by the ongoing COVID-19 pandemic.
Type of Artificial Intelligence in Healthcare
The AI technologies that play an important role in healthcare are as follows:
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.